(Q30451321)

15 September 2017

Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds (English)

1 reference

15 September 2017

Farr BM

1

1 reference

15 September 2017

Gwaltney JM Jr

series ordinal

2

1 reference

15 September 2017

Adams KF

series ordinal

3

1 reference

15 September 2017

Hayden FG

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 July 1984

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

26

1 reference

15 September 2017

1

1 reference

15 September 2017

31-34

1 reference

Automated, quantitative cytopathic effect reduction assay for interferon

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179911

The preventive effect of human interferon-alpha preparation on upper respiratory disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179911

Purified interferon as protection against rhinovirus infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179911

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179911

Inhibition of respiratory virus infection by locally applied interferon

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179911

Antiviral Activity of Intranasally Applied Human Leukocyte Interferon

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=179911

Rhinovirus infections in an industrial population. I. The occurrence of illness

20 June 2018

1 reference

12 December 2020

Human Tolerance and Histopathologic Effects of Long-Term Administration of Intranasal Interferon- 2

1 reference

12 December 2020

Unexpectedly rapid action of human interferon in physiological conditions

1 reference

12 December 2020

Rapid Onset of the Interferon-Induced Antiviral State in Human Nasal Epithelial and Foreskin Fibroblast Cells

1 reference

12 December 2020

Prophylactic Effect of Low Doses of Human Leukocyte Interferon Against Infection with Rhinovirus

1 reference

12 December 2020

Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli

1 reference

12 December 2020

The preventive effect of human interferon-alpha on influenza infection; modification of clinical manifestations of influenza in children in a closed community

1 reference

12 December 2020

Anti-interferon antibody increases rhinovirus isolation rates from nasal wash specimens containing interferon-alpha2

1 reference

12 December 2020

Intranasal Interferon 2 for Prevention of Rhinovirus Infection and Illness

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.26.1.31

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

6089652

1 reference